ANDA 74404, held by Nostrum Laboratories. Atenolol; Chlorthalidone.
As of Nov 22, 2026, ANDA 74404 (Atenolol and Chlorthalidone), held by Nostrum Laboratories, was first approved by FDA on May 14, 1998, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 14, 1998 | Original application | Approved |
| Atenolol and Chlorthalidone50MG;25MG · tablet;oral | Atenolol; Chlorthalidone | Discontinued |
| Atenolol and Chlorthalidone100MG;25MG · tablet;oral | Atenolol; Chlorthalidone | Discontinued |
| Jun 7, 2000 | Supplement 1Labeling | Approved | None posted |
| May 14, 1998 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters